Rostrum Medical and its Medical Advisory Board Welcome Dr. John Boyd

May 31, 2023 - Vancouver, B.C.

Rostrum announces the appointment of Dr. John Boyd to its Medical Advisory Board.

Dr. Boyd serves as an Associate Professor and an Intensivist at St. Paul’s Hospital and an Investigator at the Institute for Heart + Lung Health discovering solutions to challenges in critical care medicine. He received his MD from the University of Western Ontario, trained in Internal Medicine at the University of Western Ontario, and subsequently trained in Pulmonary and Critical Care Medicine at McGill University from 2001-2004. His Postdoctoral Fellowship was at the Meakins Laboratory in Montreal 2004-2005.

“On behalf of the entire team, it is my pleasure to welcome Dr. Boyd to our team”, said Awni Ayoubi, Founder and Chief Executive Officer of Rostrum Medical. “Dr. Boyd’s wide expertise and leadership in the ICU will be significant to Rostrum as we expand our clinical trials and validation across Canada, and prepare our system for commercialization. We look forward to Dr. Boyd’s additional contribution”.

About Rostrum Medical

Rostrum Medical is dedicated to empowering medical practitioners with new and useful solutions to help solve everyday challenges that medical professionals face. Rostrum was established with a goal to deliver novel solutions to problematic uncertainties in modern day practice. With a team of some of the world’s most progressive clinicians, combined with engineering and business expertise with a history of commercial success, Rostrum is driven by one mission – to address clinical needs in healthcare.

About VQm Pulmonary Health Monitor™

The VQm Pulmonary Health Monitor™ is a novel monitoring device that aims to provide clinicians with near real-time physiological insight into the effects of changes in lung mechanics of Mechanically Ventilated patients. The VQm PHM™ is being developed with the intention to assist physicians in their management of mechanical ventilation by providing measurements of the following physiological parameters: Shunt Index (Qsi), Dead space, Pulmonary Blood Flow (PBF), and Functional Residual Capacity (FRC).

 

For more information or inquiries, please email: media@rostrummedical.com

Previous
Previous

Rostrum Medical Welcomes New Advisor to Support its’ Global Commercialization Plan and Strategy

Next
Next

Rostrum Medical Innovation Partners with Toronto General Hospital for Upcoming Evaluation of its’ VQm® System